Gary Gensler’s ‘reign of terror on crypto’ will soon end, says Ripple CEO – DL News
Garlinghouse expects better engagement with the next administration. The Ripple CEO wants Gensler out. Crypto pundits are optimistic of…
Weatherford stock price target cut by Evercore ISI By Investing.com
Evercore ISI has updated its outlook on Weatherford International plc (NASDAQ: NASDAQ:), lowering the price target to $142.00 from…
Top Crypto Trader Says Large-Cap Memecoin ‘Still Turbo Strong,’ Updates Outlook on Solana and Sui
A widely followed cryptocurrency analyst and trader is leaning bullish on one memecoin while giving his forecast on two…
RBC raises Northern Trust stock price target, reaffirms Outperform rating By Investing.com
RBC Capital Markets has adjusted its outlook on Northern Trust Corporation (NASDAQ: NASDAQ:), increasing the price target to $107.00,…
From Skepticism to Strategic Reserves: Corporate Treasuries Embrace Bitcoin
Historically, only crypto-native companies held bitcoin on their balance sheets. However, a significant structural shift has occurred over the…
Piper Sandler raises Veritex Holdings stock price target By Investing.com
Piper Sandler has adjusted its outlook on Veritex Holdings (NASDAQ: NASDAQ:), raising the price target to $30 from $27,…
Nigeria releases American crypto exec after dropping money laundering case
WASHINGTON — An American cryptocurrency executive held in Nigeria for the past eight months has been released after authorities…
stock surges on merger prospects, analysts bullish By Investing.com
Primo Water Corporation (NYSE:) has been making waves in the consumer staples sector, with its stock price significantly outperforming…
U.S. will be ‘more pro-crypto’ after election, no matter who wins: Ripple CEO
Brad Garlinghouse, CEO of Ripple, speaks at the 2022 Milken Institute Global Conference in Beverly Hills, California, U.S., May…
stock outlook hinges on clinical trials By Investing.com
Arcus Biosciences, Inc. (NASDAQ:NYSE:), a biotechnology company focused on developing innovative cancer therapies, finds itself at a critical juncture…
recent post
-
Feb 04 2026 -
-
Feb 04 2026
-
Feb 04 2026
-
Feb 04 2026
